» Articles » PMID: 34768650

Methodologies for the Determination of Blood Alpha1 Antitrypsin Levels: A Systematic Review

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Nov 13
PMID 34768650
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The study of hematic concentrations of alpha1 antitrypsin (AAT) is currently one step in the diagnosis of AAT deficiency. To try to clarify the relevance of the laboratory techniques, we carried out a systematic review of the literature.

Methods: Studies evaluating the quantification of AAT in peripheral blood were searched in PubMed in July 2021. The selection criteria included (1) any type of study design that included a quantification of AAT in peripheral blood; (2) studies written in English or Spanish; (3) studies evaluating human beings; and (4) studies involving adults.

Results: Out of 207 studies, the most frequently used techniques were nephelometry (43.9%), followed by ELISA (19.8%) and turbidimetry (13.5%). Altogether, 182 (87.9%) cases expressed their results in units of gram, while 16 (7.7%) articles expressed them in units of mole. Only 2.9% articles referred to the standard used, 43.5% articles indicated the commercial kit used, and 36.2% indicated the analyzer used.

Conclusions: The technical aspects of these determinations are not always reported in the literature. Journals should be attentive to these technical requirements and ensure that they are included in the works in which AAT is determined in order to ensure a correct interpretation of the study findings.

Citing Articles

Measuring of Alpha-1 Antitrypsin Concentration by Nephelometry or Turbidimetry.

Marin-Hinojosa C, Fatela-Cantillo D, Lopez-Campos J Methods Mol Biol. 2023; 2750:123-133.

PMID: 38108973 DOI: 10.1007/978-1-0716-3605-3_12.


Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions.

Ambrosino P, Marcuccio G, Lombardi C, DAnna S, Sanduzzi Zamparelli S, Mancusi C J Clin Med. 2023; 12(20).

PMID: 37892629 PMC: 10607733. DOI: 10.3390/jcm12206490.


Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency.

Barzon V, Ottaviani S, Balderacchi A, Corino A, Piloni D, Accordino G Int J Mol Sci. 2022; 23(17).

PMID: 36077263 PMC: 9456480. DOI: 10.3390/ijms23179859.

References
1.
Lopez-Campos J, Hernandez L, Caballero Eraso C . Implications of a Change of Paradigm in Alpha1 Antitrypsin Deficiency Augmentation Therapy: From Biochemical to Clinical Efficacy. J Clin Med. 2020; 9(8). PMC: 7465600. DOI: 10.3390/jcm9082526. View

2.
Balderacchi A, Barzon V, Ottaviani S, Corino A, Zorzetto M, Wencker M . Comparison of different algorithms in laboratory diagnosis of alpha1-antitrypsin deficiency. Clin Chem Lab Med. 2021; 59(8):1384-1391. DOI: 10.1515/cclm-2020-1881. View

3.
Janciauskiene S, DeLuca D, Barrecheguren M, Welte T, Miravitlles M . Serum Levels of Alpha1-antitrypsin and Their Relationship With COPD in the General Spanish Population. Arch Bronconeumol (Engl Ed). 2019; 56(2):76-83. DOI: 10.1016/j.arbres.2019.03.001. View

4.
Mattman A, Gilfix B, Chen S, DeMarco M, Kyle B, Parker M . Alpha-1-antitrypsin molecular testing in Canada: A seven year, multi-centre comparison. Clin Biochem. 2020; 81:27-33. DOI: 10.1016/j.clinbiochem.2020.05.001. View

5.
Nakanishi T, Forgetta V, Handa T, Hirai T, Mooser V, Lathrop G . The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes. Eur Respir J. 2020; 56(6). PMC: 7726845. DOI: 10.1183/13993003.01441-2020. View